Home   >  

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

MAPK Pathway

Chemical Structure Cat. No. Product Name CAS No.
TMCB Chemical Structure
BCP27716 TMCB 905105-89-7
TMCB is a dual-kinase inhibitor. It acts by inhibiting both casein kinase 2 (CK2) and extracellular-signal-regulated kinase 8 (ERK8).
LY2322600 Chemical Structure
BCP27665 LY2322600 862505-01-9
LY2228820 is a novel and potent p38MAPK inhibitor.
D-87503 Chemical Structure
BCP27634 D-87503 800394-83-6
D-87503 is a dual extracellular signaling-related kinase (ERK)/PI3K inhibitor.
CC-90003 Chemical Structure
BCP23624 CC-90003 1621999-82-3
CC-90003 is an irreversible and selective inhibitor of ERK 1/2 with antitumor activity.
MK-8353 Chemical Structure
BCP23615 MK-8353 1184173-73-6
MK-8353 is a potent, selective and orally available ERK1/2 inhibitor, with IC50s of 23.0 nM and 8.8 nM, respectively; MK-8353 has antitumor activity.
AT7867 dihydrochloride Chemical Structure
BCP30936 AT7867 dihydrochloride 1431697-86-7
AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1/Akt2/Akt3 and p70S6K/PKA with IC50s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.
ETC206 Chemical Structure
BCP30906 ETC206 1464151-33-4
ETC-206 is a selective MNK1 and MNK2 inhibitor with IC50s of 64 nM and 86 nM, respectively.
DMX-5084 Chemical Structure
BCP30841 DMX-5084 2306178-56-1
DMX-5804 is a potent, orally active and selective MAP4K4 inhibitor.
MW-150 dihydrochloride dihydrate Chemical Structure
BCP30837 MW-150 dihydrochloride dihydrate 1661020-92-3
MW-150 dihydrochloride dihydrate is a selective inhibitor of p38αMAPK isoform with a Ki of 101 nM.
Ulixertinib hydrochloride Chemical Structure
BCP30834 Ulixertinib hydrochloride 1956366-10-1
Ulixertinib hydrochloride is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib hydrochloride inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line.
123下一页末页共 195 条记录 1 / 20 页 
0086-13720134139